Terlipressin avoids hemodialysis in the treatment of refractory hyperkalemia associated with renal dysfunction in cirrhosis

dc.contributor.author	Kalambokis, G.	en
dc.contributor.author	Milionis, H.	en
dc.contributor.author	Elisaf, M. S.	en
dc.contributor.author	Tsianos, E. V.	en
dc.date.accessioned	2015-11-24T19:42:45Z
dc.date.available	2015-11-24T19:42:45Z
dc.identifier.issn	0002-9343	-
dc.identifier.uri	https://olympias.lib.uoi.gr/jspui/handle/123456789/24687
dc.rights	Default Licence	-
dc.subject	Hepatorenal Syndrome/*complications	en
dc.subject	Humans	en
dc.subject	Hyperkalemia/drug therapy/etiology	en
dc.subject	Liver Cirrhosis/*complications	en
dc.subject	Lypressin/*analogs & derivatives/therapeutic use	en
dc.subject	Male	en
dc.subject	Middle Aged	en
dc.subject	Renal Agents/*therapeutic use	en
dc.title	Terlipressin avoids hemodialysis in the treatment of refractory hyperkalemia associated with renal dysfunction in cirrhosis	en
heal.access	campus	-
heal.fullTextAvailability	TRUE	-
heal.identifier.primary	10.1016/j.amjmed.2005.04.007	-
heal.identifier.secondary	http://www.ncbi.nlm.nih.gov/pubmed/16164896	-
heal.identifier.secondary	http://ac.els-cdn.com/S0002934305002809/1-s2.0-S0002934305002809-main.pdf?_tid=13d119699d8e1ae69a8784acdb853391&acdnat=1334041797_550e2149dc38cdcb5cbbced83325bc00	-
heal.journalName	Am J Med	en
heal.journalType	peer-reviewed	-
heal.language	en	-
heal.publicationDate	2005	-
heal.recordProvider	Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής	el
heal.type	journalArticle	-
heal.type.el	Άρθρο Περιοδικού	el
heal.type.en	Journal article	en

Αρχεία

Προβολή: 1 - 1 of 1